Recall: Platinum, Slimming Plus and more Dietary Supplements

On 2018-07-06, the FDA announced that MyNicNaxs is conducting a recall on Dietary Supplements due to a possible active pharmaceutical ingredient (api). The recalled products were sold under the brand name(s) Platinum and Slimming Plus and more during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 1 drugs recalls due to potential undeclared ingredients, including male enhancement, dietary supplement and more. Additionally, there have been 24 drug and medical device recalls due to other health hazards as well as 79 food recalls.

Company Contact Information:

Name: MyNicNaxs
Website: http://www.mynicnaxs.com
Phone: 386-337-8142

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information

Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: dietary supplements

Brand Name(s): Platinum, Slimming Plus and more

Reason for Recall: Undeclared Active Pharmaceutical Ingredient (API)

Official Recall Date: 2018-07-06

Additional information provided by the FDA.gov:

MyNicNaxs, LLC, Deltona, FL is voluntarily recalling all lots of dietary supplements distributed nationwide to the consumer level. The products have been found to contain undeclared active pharmaceutical ingredients (API)The presence of Sildenafil, Sibutramine, Diclofenac and/or Phenolphthalein in the dietary supplements renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. These products were distributed from January 2013, to December 2017, though our website http://www.mynicnaxs.com. The undeclared drug ingredients found in these products may pose serious health risks because consumers with underlying medical issues may take them without knowing that they can cause serious harm or interact in dangerous ways with other drugs they may be taking. API found in FDA samples include the following: Read More.

More information may be available at FDA.gov